6. Additional research is needed to investigate effective means of depression prevention in patients with diabetes.
7. Additional research is needed to establish the cost-effectiveness of all modes of depression treatment in patients with T1D and T2D.
Recommendations for Screening and Care
Depression is a frequent comorbid condition in patients with T1D and T2D. The following recommendations for clinical care are based on the literature and expert opinion (Evans 2005):
1. Depression screening is recommended at every visit for diabetes patients, accompanied by procedures to review patient responses and address clinically significant levels of symptoms. Increased concern is indicated for patients presenting with elevated blood glucose and with worsening diabetes complications and those who report a lifetime history of depression and may therefore be at increased risk for future depressive episodes. Providers may use a variety of brief screening tools to detect depressive symptoms in diabetes patients.
2. Providers are recommended to maintain a low threshold for depression treatment and promote rigorous, ongoing treatment of depression, once identified. Adequate adjustment of dosing for antidepressant medications, well-monitored maintenance therapy, and referrals to mental health services should be routinely provided by health care providers. Coordination of depression and diabetes care across providers is also recommended to ensure adequate depression treatment and follow-up care in light of the persistence and recurrence of depression in diabetes patients and the association with poor medical management.
3. Evidence supports the use of a stepped-care approach (medication and therapy) and monitored maintenance therapy to achieve symptom remission and improvements in glycemic control.
4. Use of a collaborative care approach that integrates therapy and antidepressant medication within primary care settings is suggested. This intervention paradigm has demonstrated the capacity to reduce some barriers, such as social stigma, to the effective treatment of depression in diabetes patients and has been shown to be cost-effective to health care organizations.
5. Incorporation of depression curricula into diabetes education and routine communication with patients about the role of depression in diabetes outcomes is recommended to reduce patient perceptions of stigma associated with mental illness and improve patient awareness of treatment options.
6. Incorporation of depression screening measures into clinical care outcomes within health care organizations is recommended.
BIBLIOGRAPHY
Ali S, Stone MA, Peters JL, Davies MJ, Khunti K: The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med 23:1165–1173, 2006
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders - DSM-IV-TR. 4th ed. Washington, D.C., American Psychiatric Association, 2000
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24:1069–1078, 2001
Arroyo CG, Hu FB, Ryan L, Kawachi I, Colditz G, Speizer F, Manson J: Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 27:129–133, 2004
Asghar S, Hussain A, Alit SMK, Khan AKA, Magnusson A: Prevalence of depression and diabetes: a population-based study from rural Bangladesh. Diabet Med 24:872–877, 2007
Barnard KD, Skinner TC, Peveler R: The prevalence of co-morbid depression in adults with type 1 diabetes: systematic literature review. Diabet Med 23:445–448, 2006
Beck AT, Steer RA, Brown GK: BDI-II Beck Depression Inventory Manual. 2nd ed. San Antonio, TX, The Psychological Corporation, Harcourt, Brace & Company, 1996
Bruce DG, Davis WA, Davis TME: Longitudinal predictors of reduced mobility and physical disability in patients with type 2 diabetes. Diabetes Care 28:2441–2447, 2005
Carnethon M, Biggs M, Barzilay JJ, Smith N, Vaccarino V, Bertoni AG, Arnold A, Siscovick D: Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the Cardiovascular Health Study. Arch Intern Med 167:802–807, 2007
Carnethon M, Kinder L, Fair J, Stafford R, Fortmann S: Symptoms of depression as a risk factor for incident diabetes: findings from the National Health and Nutrition Examination Epidemiologic Follow-Up Study, 1971–1992. Am J Epidemiol 158:416–423, 2003
Ciechanowski PS, Russo JE, Katon WJ, Von Korff M, Simon GE, Lin EHB, Ludman EJ, Young BA: The association of patient relationship style and outcomes in collaborative care treatment for depression in patients with diabetes. Med Care 44:283–291, 2006
Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 160:3278–3285, 2000
Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM: Depression and coronary heart disease in women with diabetes. Psychosom Med 65:376–383, 2003
de Groot M, Doyle T, Hockman E, Wheeler C, Pinkerman B, Shubrook J, Gotfried R, Schwartz F: Depression among type 2 diabetes rural Appalachian clinic attenders. Diabetes Care 30: 1602–1604, 2007
de Groot M, Pinkerman B, Wagner J, Hockman E: Depression treatment and satisfaction in a multicultural sample of type 1 and type 2 diabetic patients. Diabetes Care 29:549–553, 2006
de Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: Association of depression and diabetes complications: a meta-analysis. Psychosom Med 63:619–630, 2001
Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE: Depression and risk for onset of type 2 diabetes. Diabetes Care 19:1097–1102, 1996
Egede LE: Diabetes, major depression and functional disability among U.S. adults. Diabetes Care 27:421–428, 2004
Egede LE, Zheng D: Independent factors associated with major depressive disorder in a national sample of individuals with diabetes. Diabetes Care 26:104–111, 2003
Egede LE: Beliefs and attitudes of African Americans with type 2 diabetes toward depression. Diabetes Educ 28:258–268, 2002a
Egede LE, Zheng D, Simpson K: Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 25:464–470, 2002b
Engum A: The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 62:31–38, 2007
Erdman HP, Klein MH, Greist JH, Skare SS, Husted JJ, Robins LN, Helzer JE, Goldring E, Hamburger M, Miller JP: A comparison of two computer-administered versions of the NIMH Diagnostic Interview Schedule. J Psychiatr Res 26:85–95, 1992
Evans D, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KRR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58:175–189, 2005
Finkelstein, EA, Bray JW, Chen H, Larson MJ, Miller K, Tompkins C, Keme A, Manderscheid R: Prevalence and costs of major depression among elderly claimants with diabetes. Diabetes Care 26:415–420, 2003
Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, Glasgow R, Laurencin G: Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care 30:542–548, 2007
Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA: Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care 24:1751–1757, 2001
Gary TL, Baptiste-Roberts K, Crum RM, Cooper LA, Ford DE, Brancati FL: Changes in depressive symptoms and metabolic control over 3 years among African Americans with type 2 diabetes. Int J Psychiatry Med 35:377–382, 2005
Gary